Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
This is a phase IV, multicenter, randomized, double blind clinical trial. The investigators will study 48 patients with remitting relapsing multiple sclerosis (MS) experiencing moderate or severe attack receiving immunomodulatory therapy or not. Patients will be randomly assigned to one of the two groups.
Epistemonikos ID: eb00b2ae5b2dbed6bf2978f8a9d55a1593f5fea1
First added on: Mar 31, 2022